We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Rituximab Maintenance Therapy for Marginal Zone B-cell Lymphoma (MZL)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01213095
First Posted: October 1, 2010
Last Update Posted: April 11, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Sung Yong Oh, Dong-A University Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2015
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)